Podcasts
ToxChats©

ToxChats©

ACT ToxChats 53 - Infectious Disease Outbreaks and Disease Elimination in the 21st Century: Reflections from the 2025 ACT Plenary Speaker

The American College of Toxicology podcast program, ToxChats ©, reports on cutting-edge news in toxicological research from around the globe.

Volume

00:00

Geen beschrijving van de aflevering beschikbaar.

Gepubliceerd 22 sep. 2026

Duur 38:52

Zoeken

Afleveringen

53-

Infectious Disease Outbreaks and Disease Elimination in the 21st Century: Reflections from the 2025 ACT Plenary Speaker

Beluisterd

22 sep. 2026

52-

Weight of Evidence Approach to Carcinogenicity: An Interview with Todd Bourcier and Tim McGovern

Beluisterd

31 jul. 2026

51-

Next-Gen Toxicology: Inside the Organ Chip Revolution with Dr. Donald Ingber

Beluisterd

01 mei 2026

50-

Transitioning from Industry to Consulting, Independent vs. Firm Consultant

Beluisterd

27 feb. 2026

49-

Human and Environmental Health Topic: Next Generation Risk Assessment

Beluisterd

07 nov. 2025

48-

The Science of Mentorship: A Conversation with Richard DiMarchi

Beluisterd

15 okt. 2025

47-

From RIF to Reboot: A Guide for Early to Mid-Career Toxicologists

Beluisterd

30 sep. 2025

46-

Discussing the FDA's Announcement to Phase Out Animal Testing in Monoclonal Antibody Development

Beluisterd

17 jul. 2025

45-

Specialty Tox Topic: In Vivo Dermal Drug Development

Beluisterd

07 jul. 2025

44-

Specialty Tox Topic: In Vitro Dermal Drug Development

Beluisterd

23 jun. 2025

43-

Occupational Toxicology and Product Quality: Navigating Impurities and Occupational Safety

Beluisterd

05 mei 2025

42-

The Past, Present, and Future of Safety Pharmacology

Beluisterd

01 apr. 2025

41-

Career Path: Toxicologist in the Food Industry

Beluisterd

03 feb. 2025

40-

Changing Approaches to Getting Drug Candidates into First-in-Human Clinical Trials: A Case Study

Beluisterd

18 dec. 2024

39-

Career Path: Pharmaceutical Consultant in the Field of Toxicology

Beluisterd

04 nov. 2024

38-

3D Printing Emissions and Potential Health Effects from a Consumer Perspective

Beluisterd

02 sep. 2024

37-

Career Path: Pharmaceutical Consultant in the Field of Occupational, Environmental, and Quality Toxicology

Beluisterd

16 aug. 2024

36-

Discussions on Identifying Seizures Liability in Nonclinical Studies

Beluisterd

01 jul. 2024

35-

Alternative and Nontraditional Species Series: The Use of Transgenic and Disease Mouse Animal Models for Toxicology Studies

Beluisterd

06 mei 2024

34-

Identifying an Appropriate Sponsor to Support Your Growth and Success in the Workplace

Beluisterd

04 mrt. 2024

33-

Alternative and Nontraditional Species Series: Fertilized Egg Model as an Alternative Species for Safety Assessment Studies

Beluisterd

29 jan. 2024

32-

Alternative and Nontraditional Species Series: Advantages and Challenges of Using Rabbits

Beluisterd

22 jan. 2024

31-

Alternative and Nontraditional Species Series: Sheep as an Alternative Model for the Safety Evaluation of Medical Devices

Beluisterd

15 jan. 2024

30-

Alternative and Nontraditional Species Series: Mini Pig–Alternatives to Traditional Nonrodent Models in Nonclinical Safety Testing

Beluisterd

08 jan. 2024

29-

Medical Devices: Safety Evaluation and Becoming a Medical Device Toxicologist

Beluisterd

28 nov. 2023

28-

Interviewing and Negotiation 101 for Toxicologist Roles in the Biopharmaceutical Industry

Beluisterd

05 sep. 2023

27-

The History and Future of Oligonucleotide Drug Development

Beluisterd

05 jul. 2023

26-

The Opioid Crisis: Misconceptions, History, and Interventions

Beluisterd

28 apr. 2023

25-

Covid-19 Part 2: New Type of Antibody-Dependent Enhancement Associated with SARS-CoV-2 Virus: MIS-C, MIS-A, and MIS-N

Beluisterd

03 mrt. 2023

24-

Covid-19 Part 1: Antibody-dependent Enhancement of Disease

Beluisterd

06 jan. 2023

23-

Artificial Intelligence (AI) Use in Toxicology

Beluisterd

03 nov. 2022

22-

Overview of mRNA Vaccines

Beluisterd

08 sep. 2022

21-

Tips for Taking the ABT Exam

Beluisterd

16 jun. 2022

20-

Moving from Minion to Manager

Beluisterd

26 mei 2022

19-

Off the Beaten Path: The Nonclinical Development of Gene Therapy Products to Cure Monogenic Diseases

Beluisterd

24 mrt. 2022

18-

Digital Pathology

Beluisterd

20 jan. 2022

17-

Expedited FDA Programs

Beluisterd

17 jun. 2021

16-

Toxicology Salary Survey

Beluisterd

13 mei 2021

15-

Pediatric Drug Development

Beluisterd

04 mrt. 2021

14-

CAR/T: New Modalities Paving the Way for Cancer

Beluisterd

06 jan. 2021

13-

History and Risk Assessment of Vaccines—Q&A

Beluisterd

05 nov. 2020

12-

Scientific Communication: Distilling and Rehearsing to Reach Your Audience

Beluisterd

20 aug. 2020

11-

AI and Big Data for Safety Testing

Beluisterd

27 apr. 2020

10-

Shining a Light on the Science and Strategy of Phototoxicity Assessments

Beluisterd

10 apr. 2020

The Twists and Turns of GI Health and Medicine: An Interview with Dr. Alessio Fasano

Beluisterd

10 feb. 2020

The Scientific Approach to Address Uncommon Routes and Best Practices for Forming a Working Group

Beluisterd

03 okt. 2019

CRISPR Then and Now: An Interview with Dr. Jacob Corn, ACT 2015 Plenary Speaker

Beluisterd

16 aug. 2019

In Vitro and Alternative Models for Regulatory Submission

Beluisterd

30 nov. 2018

Regulation of E-Cigarettes

Beluisterd

19 jul. 2018

The Opioid Epidemic

Beluisterd

26 apr. 2018